COMPOSITIONS COMPRISING DARUNAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FOR USE IN THE TREATMENT OF HIV

COMPOSITIONS COMPRISING DARUNAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FOR USE IN THE TREATMENT OF HIV

The disclosure is directed to methods of treating subjects infected with HIV, once daily, with single unit dosage forms that include darunavir (or a hydrate or solvate thereof), cobicistat, emtricitabine, and a tenofovir prodrug, or salt thereof. L'invention concerne des procédés de traitement...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MERTENS, ROEL, OPSOMER, MAGDA, HENRIST, DOMINIEK, BOVEN, KATIA, MCCALLISTER, SCOTT, PRYZ, WILLIAM, DRIESEN, REGINA, MATHUR, SANDEEP, ZIA, VAHID, DE SMEDT, GOEDELE, KAUWENBERGHS, GREET, NETTLES, RICHARD
Format: Patent
Sprache:eng ; fre
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The disclosure is directed to methods of treating subjects infected with HIV, once daily, with single unit dosage forms that include darunavir (or a hydrate or solvate thereof), cobicistat, emtricitabine, and a tenofovir prodrug, or salt thereof. L'invention concerne des procédés de traitement de sujets infectés par le VIH, une fois par jour, avec des formes posologiques unitaires uniques qui comprennent du darunavir (ou un hydrate ou un solvate de celui-ci), du cobicistat, de l'emtricitabine, et un promédicament de ténofovir, ou un sel de celui-ci.